uniQure

red light green light
Biotech

UniQure stock surges after FDA U-turn clears path to filing

The FDA gave the biotech the OK to file for accelerated approval after previously demanding data from another trial.
Nick Paul Taylor Jun 17, 2026 9:10am
two arrows pointing different directions
Favicon Fierce Pharma

FDA to reconsider rejected cell therapy. Could uniQure be next?

May 7, 2026 10:40am
light bulb think theory idea bright dull lights out

Small pools, big ideas: Rare disease community reimagines trials

Apr 17, 2026 3:00am
The Capitol Building in Washington DC with bright blue sky - stock photo Becky WrightGetty Images

‘Bureaucratic idiocy’: GOP senator to investigate FDA rejections

Mar 10, 2026 11:10am
FDA stop sign

Senior FDA official fires back at uniQure amid controversy

Mar 5, 2026 3:33pm
tennis racket hitting ball

UniQure, FDA back-and-forth intensifies

Mar 5, 2026 11:55am